Lack of Syndecan-1 produces significant alterations in whole-body composition, metabolism and glucose homeostasis in mice.
Energy expenditure
Feeding pattern
High fat diet
IL-17
Indirect calorimetry
Syndecan-1
Journal
World journal of diabetes
ISSN: 1948-9358
Titre abrégé: World J Diabetes
Pays: United States
ID NLM: 101547524
Informations de publication
Date de publication:
15 Apr 2020
15 Apr 2020
Historique:
received:
23
10
2019
revised:
20
12
2019
accepted:
08
02
2020
entrez:
22
4
2020
pubmed:
22
4
2020
medline:
22
4
2020
Statut:
ppublish
Résumé
Obesity is a disease state with serious adverse metabolic complications, including glucose intolerance and type 2 diabetes that currently has no cure. Identifying and understanding roles of various modulators of body composition and glucose homeostasis is required for developing effective cures. Syndecan-1 (Sdc1) is a member of the heparan sulfate proteoglycan family that has mainly been investigated for its role in regulating proliferation and survival of epithelia and tumor cells, but little is known about its roles in regulating obesity and glucose homeostasis. To examine the role of Sdc1 in regulating body fat and glucose metabolism. We used female wild type and Sdc1 knockout (Sdc1 KO) mice on BALB/c background and multiple methods. Metabolic measurements (rates of oxygen consumption, carbon dioxide production, respiratory exchange ratio and energy expenditure) were performed using an open-flow indirect calorimeter with additional features to measure food intake and physical activity. Glucose intolerance and insulin resistance were measured by established tolerance test methods. Although our primary goal was to investigate the effects of Sdc1 deficiency on body fat and glucose homeostasis, we uncovered that Sdc1 regulates multiple metabolic parameters. Sdc1KO mice have reduced body weight due to significant decreases in fat and lean masses under both chow and high fat diet conditions. The reduced body weight was not due to changes in food intakes, but Sdc1 KO mice exhibited altered feeding behavior as they ate more during the dark phase and less during the light phase than wild type mice. In addition, Sdc1 KO mice suffered from high rate of energy expenditure, glucose intolerance and insulin resistance. These results reveal critical multisystem and opposing roles for Sdc1 in regulating normal energy balance and glucose homeostasis. The results will have important implications for targeting Sdc1 to modulate metabolic parameters. Finally, we offer a novel hypothesis that could reconcile the opposing roles associated with Sdc1 deficiency.
Sections du résumé
BACKGROUND
BACKGROUND
Obesity is a disease state with serious adverse metabolic complications, including glucose intolerance and type 2 diabetes that currently has no cure. Identifying and understanding roles of various modulators of body composition and glucose homeostasis is required for developing effective cures. Syndecan-1 (Sdc1) is a member of the heparan sulfate proteoglycan family that has mainly been investigated for its role in regulating proliferation and survival of epithelia and tumor cells, but little is known about its roles in regulating obesity and glucose homeostasis.
AIM
OBJECTIVE
To examine the role of Sdc1 in regulating body fat and glucose metabolism.
METHODS
METHODS
We used female wild type and Sdc1 knockout (Sdc1 KO) mice on BALB/c background and multiple methods. Metabolic measurements (rates of oxygen consumption, carbon dioxide production, respiratory exchange ratio and energy expenditure) were performed using an open-flow indirect calorimeter with additional features to measure food intake and physical activity. Glucose intolerance and insulin resistance were measured by established tolerance test methods.
RESULTS
RESULTS
Although our primary goal was to investigate the effects of Sdc1 deficiency on body fat and glucose homeostasis, we uncovered that Sdc1 regulates multiple metabolic parameters. Sdc1KO mice have reduced body weight due to significant decreases in fat and lean masses under both chow and high fat diet conditions. The reduced body weight was not due to changes in food intakes, but Sdc1 KO mice exhibited altered feeding behavior as they ate more during the dark phase and less during the light phase than wild type mice. In addition, Sdc1 KO mice suffered from high rate of energy expenditure, glucose intolerance and insulin resistance.
CONCLUSION
CONCLUSIONS
These results reveal critical multisystem and opposing roles for Sdc1 in regulating normal energy balance and glucose homeostasis. The results will have important implications for targeting Sdc1 to modulate metabolic parameters. Finally, we offer a novel hypothesis that could reconcile the opposing roles associated with Sdc1 deficiency.
Identifiants
pubmed: 32313611
doi: 10.4239/wjd.v11.i4.126
pmc: PMC7156300
doi:
Types de publication
Journal Article
Langues
eng
Pagination
126-136Informations de copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: Authors declare no conflict of interest.
Références
Annu Rev Biochem. 1999;68:729-77
pubmed: 10872465
World J Diabetes. 2017 Apr 15;8(4):130-134
pubmed: 28465789
J Clin Pathol. 2008 Jun;61(6):697-706
pubmed: 18505888
Matrix Biol. 2012 Jan;31(1):3-16
pubmed: 22033227
Nat Rev Immunol. 2018 Sep;18(9):559-574
pubmed: 29967365
PLoS Genet. 2014 Aug 07;10(8):e1004514
pubmed: 25101993
J Biol Chem. 2010 Jan 1;285(1):286-94
pubmed: 19889634
PLoS One. 2012;7(10):e46562
pubmed: 23049707
Front Immunol. 2019 Jul 17;10:1587
pubmed: 31379820
Ann N Y Acad Sci. 2003 Jun;994:66-73
pubmed: 12851299
J Immunol. 2010 Dec 1;185(11):6947-59
pubmed: 21037091
Curr Pharm Des. 2008;14(12):1225-30
pubmed: 18473870
Eur J Immunol. 2015 Nov;45(11):3045-51
pubmed: 26300525
J Clin Invest. 2009 Nov;119(11):3236-45
pubmed: 19805913
J Biol Chem. 2001 Dec 14;276(50):47483-8
pubmed: 11585825
J Clin Invest. 2004 Nov;114(9):1354-60
pubmed: 15520868
Biochem Biophys Res Commun. 2016 May 20;474(1):15-21
pubmed: 27018253
Cell. 2001 Jul 13;106(1):105-16
pubmed: 11461706
Obesity (Silver Spring). 2012 Aug;20(8):1628-38
pubmed: 21494229
Proc Nutr Soc. 2012 May;71(2):332-8
pubmed: 22429824
Open Biochem J. 2017 Sep 21;11:77-93
pubmed: 29151984
J Immunol. 2018 Sep 15;201(6):1651-1661
pubmed: 30045969
J Cell Sci. 2002 Dec 1;115(Pt 23):4517-31
pubmed: 12414997
Science. 2013 Nov 8;342(6159):727-30
pubmed: 24202171
Front Neurosci. 2017 Feb 07;11:23
pubmed: 28223912
J Clin Invest. 2001 Jan;107(2):R9-R14
pubmed: 11160142
Cold Spring Harb Perspect Biol. 2011 Jul 01;3(7):
pubmed: 21690215